Bankrupt Dendreon Taps Valeant As $400M Stalking Horse
A Delaware bankruptcy judge on Thursday blessed Dendreon Corp.'s selection of Valeant Pharmaceuticals International Inc. as a $400 million stalking horse, following a bidding war that saw Valeant add $104 million...To view the full article, register now.
Already a subscriber? Click here to view full article